Generics News

Upsher-Smith Launches Generic Qudexy XR

Upsher-Smith announced the launch of Topiramate Extended-Release Capsules, the generic version of its recently approved Qudexy XR (topiramate) extended-release capsules.

Par Launches Fluphenazine Decanoate Injection

Par Pharmaceuticals announced that it has received final approval from the FDA for Fluphenazine Decanoate Injection.

FDA Approves Generic Advil Congestion Relief

Perrigo has announced that the FDA has approved Ibuprofen and Phenylephrine HCl Tablets, the generic version of Pfizer Consumer's Advil Congestion Relief.

Mylan Launches Generic Micardis

Mylan announced that it has launched Telmisartan Tablets, the generic version of Boehringer Ingelheim's Micardis.

Generic Testosterone Gel in 3 Forms Launched

Upsher-Smith announced the launch of Testosterone Gel 1%, the generic version of Vogelxo gel, in 3 different configurations.

Ohm Labs Approved for Generic Diovan

Ohm Laboratories announced it has received approval from the FDA to manufacture and market Valsartan Tablets, the generic version of Novartis' Diovan.

Dr. Reddy's Launches Generic Cymbalta

Dr. Reddy's Laboratories announced the launch of Duloxetine Delayed-Release Capsules, the generic version of Eli Lilly's Cymbalta.

Dr. Reddy's Launches Generic Zemplar

Dr. Reddy's Laboratories announced the launch of Paricalcitol Capsules, the generic version of AbbVie's Zemplar.

Lannett Approved for Codeine Sulfate Tablets

Lannett announced it has received FDA approval of its Abbreviated New Drug Application (ANDA) for Codeine Sulfate Tablets, the equivalent version of Roxane Laboratories' Codeine Sulfate.

Breckenridge Launches Generic Cymbalta

Breckenridge announced the launch of Duloxetine Delayed-Release Capsules, the generic version of Eli Lilly's Cymbalta.